Alcohol intake has been implicated as a cause for refractory hypertension which constitutes a major health problem. The nature and the mechanism(s) of the hemodynamic interaction between alcohol and different antihypertensive medications, which may vary both in magnitude and direction, have received little attention. The general aim of the proposed studies is to focus on the mechanism(s) of the antagonistic hemodynamic interaction between alcohol and centrally acting antihypertensive drugs. Renewed interest in utilizing this class of drugs and particularly the second generation drugs, e.g. rilmenidine, as a first line monotherapy for the treatment of hypertension makes the proposed studies noteworthy. The newer drugs lack the sedative side effect of clonidine but lower blood pressure by the same mechanism. The proposed studies will therefore focus on the action of ethanol on the primary processes that lead to the hypotensive responses elicited by this class of drugs which are triggered by activation of the imidazoline receptor complex at their major site of action, the rostral ventrolateral medulla. Given the widespread use of alcohol, studies that deal with its action on the central pathways involved in the hemodynamic responses elicited by centrally acting drugs are warranted.
The first aim i s intended. to gain support to the hypothesis that the adverse effect of alcohol is targeted against the subclass of centrally acting drugs that lower blood pressure by activating the imidazoline receptor complex.
The second aim i s to investigate the mechanism(s) of this adverse hemodynamic interaction. The hypothesis is tested that the adverse hemodynamic effects of ethanol involve reversal of the electrochemical responses triggered by clonidine or rilmenidine at their major site of the hypotensive action, the rostral ventrolateral medulla (RVLM) via a selective interaction with the nonadrenergic imidazoline receptor complex. Further studies will determine the site and receptor selectivity of the action of ethanol.
The third aim i s to test the hypothesis that attenuation of the hypotensive responses elicited by clonidine administered concurrently with alcohol or acutely to alcohol-fed rats involves alcohol evoked modification of the binding characteristics of the imidazoline receptor complex in the rostral ventrolateral medulla, the major site of the hypotensive action of clonidine and the second generation drugs. Whether a pharmacokinetic interaction is involved in the chronic infraction between alcohol and clonidine will be investigated. The experiments proposed herein are intended to test these hypotheses in unrestrained conscious spontaneously hypertensive and normotensive rats chronically instrumented for hemodynamic and electrochemical measurements. These studies are expected to provide significant new insights about the effect of ethanol intake on the hypotensive responses elicited by activating central imidazoline receptors and the mechanism(s) of this health related hemodynamic interaction. In addition to gaining basic knowledge about the neurobiological effects of alcohol on the cardiovascular system, these studies are expected to yield clinically relevant information that could have significant outcome on the treatment of hypertension in alcohol using individuals.

Agency
National Institute of Health (NIH)
Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Type
Research Project (R01)
Project #
5R01AA007839-09
Application #
2748425
Study Section
Biochemistry, Physiology and Medicine Subcommittee (ALCB)
Project Start
1988-09-01
Project End
2000-07-31
Budget Start
1998-08-01
Budget End
2000-07-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
East Carolina University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
City
Greenville
State
NC
Country
United States
Zip Code
27858
Abdel-Rahman, Abdel A (2017) Influence of sex on cardiovascular drug responses: role of estrogen. Curr Opin Pharmacol 33:1-5
McGee, Marie A; Abdel-Rahman, Abdel A (2016) N-Methyl-D-Aspartate Receptor Signaling and Function in Cardiovascular Tissues. J Cardiovasc Pharmacol 68:97-105
Ibrahim, Badr Mostafa; Abdel-Rahman, Abdel A (2015) A pivotal role for enhanced brainstem Orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats. Brain Res 1622:51-63
McGee, Marie A; Abdel-Rahman, Abdel A (2015) Ethanol attenuates peripheral NMDAR-mediated vascular oxidative stress and pressor response. Alcohol 49:499-506
Penumarti, Anusha; Abdel-Rahman, Abdel A (2014) The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure. J Pharmacol Exp Ther 349:29-38
McGee, Marie A; Abdel-Rahman, Abdel A (2014) Enhanced vascular PI3K/Akt-NOX signaling underlies the peripheral NMDAR-mediated pressor response in conscious rats. J Cardiovasc Pharmacol 63:395-405
El-Mas, Mahmoud M; Abdel-Rahman, Abdel A (2014) Ser/thr phosphatases tonically attenuate the ERK-dependent pressor effect of ethanol in the rostral ventrolateral medulla in normotensive rats. Brain Res 1577:21-8
Ibrahim, Badr M; Abdel-Rahman, Abdel A (2014) Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review. J Adv Res 5:137-45
Penumarti, Anusha; Abdel-Rahman, Abdel A (2014) Neuronal nitric oxide synthase-dependent elevation in adiponectin in the rostral ventrolateral medulla underlies g protein-coupled receptor 18-mediated hypotension in conscious rats. J Pharmacol Exp Ther 351:44-53
El-Mas, Mahmoud M; Fan, Ming; Abdel-Rahman, Abdel A (2013) Role of rostral ventrolateral medullary ERK/JNK/p38 MAPK signaling in the pressor effects of ethanol and its oxidative product acetaldehyde. Alcohol Clin Exp Res 37:1827-37

Showing the most recent 10 out of 28 publications